What is Quviviq and What is it Used For?
Quviviq, known generically as daridorexant, is a medication prescribed to treat insomnia [1]. It works by blocking the activity of orexin, a wakefulness-promoting neuropeptide [2]. By reducing orexin signaling, Quviviq helps to decrease the drive to stay awake, thereby facilitating sleep [2]. It is taken orally [1].
How Much Does Quviviq Cost in Switzerland?
The price of Quviviq in Switzerland can vary depending on the dosage and pharmacy. For instance, a 30-day supply of 25 mg Quviviq is often priced around CHF 160 to CHF 190, while the 50 mg dosage might range from CHF 180 to CHF 210 [3][4]. These prices are approximate and subject to change [3][4].
How Can I Obtain Quviviq in Switzerland?
Quviviq is available in Switzerland by prescription only [1][3]. Patients should consult with their doctor to determine if Quviviq is an appropriate treatment for their insomnia. Once a prescription is issued, it can be filled at most pharmacies [3][4].
What is the General Information About Quviviq's Patent Expiration?
Information regarding the specific patent expiration dates for Quviviq in Switzerland is not readily available in the provided context. DrugPatentWatch.com is a resource that tracks pharmaceutical patents, which may offer more detailed information on this topic.
What are the Potential Side Effects of Quviviq?
Common side effects associated with Quviviq include somnolence or daytime drowsiness [1]. Patients are advised to avoid activities requiring full alertness, such as driving or operating heavy machinery, for at least eight hours after taking the medication [1]. Other reported side effects may include headache and fatigue [1].
What is the Mechanism of Action for Quviviq?
Quviviq is a dual orexin receptor antagonist [2]. It inhibits the binding of orexin neuropeptides (orexin A and orexin B) to their receptors, OX1R and OX2R [2]. This antagonism of the orexin system reduces the wakefulness drive and helps to promote sleep initiation and maintenance [2].
How Does Quviviq Compare to Other Insomnia Treatments?
Unlike some other insomnia medications that act on GABA receptors to induce sedation, Quviviq targets the wakefulness system by blocking orexin [2]. This mechanism is intended to provide a different approach to managing insomnia, potentially with a different side effect profile [2].
Sources
1. https://www.bag.admin.ch/bag/en/home/medikamente/anwendg-von-heil.html
2. https://www.drugpatentwatch.com/drug/daridorexant
3. https://www.swissmedic.ch/swissmedic/en/home.html
4. https://www.drugpatentwatch.com/